Skip to main content
Skip to content

Duplicate Document

This document appears to be a copy. The original version is:

EFTA Document EFTA01493716
Case File
efta-efta01493716DOJ Data Set 10Correspondence

EFTA Document EFTA01493716

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01493716
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
FINANCIAL TRUST COMPANY INC ACCT. For the Period 12/1/12 to 12/31/12 Note: ** Unrealized Gainloss is shown as "N/A" in cases where we do not have appropriate cost information for all tax lots comprising the posdion Please contact your J.P. Morgan team for additional information. Equity Detail Price Quantity Value Adjusted Tax Cost Unrealized Gain/Loss Est. Annual Inc. Yield Original Cost Accrued Div. US Large Cap Equity ARIAD PHARMACEUTICALS INC 19.18 16,535.000 317,141.30 251,475.52 65,665.78 04033A-10-0 ARIA BIOGEN IDEC INC 148.37 2,095.000 306,645.15 250,454.95 56,190.20 09082X-10-31311B DEAN FOODS CO 16.51 25,000.000 412,750.00 470,439.75 (57,689.75) 242370-10-4 DF FACEBOOK INC-A 26.62 465,850.00 665,000.00 (199,150.00) 17,500.000 30303M-10-2 FB Total US Lary Cap Equity 01,602,380.45 51.637 370 22 ($134,083.77) *0.00 0.00% US Small/Mid Cap Equity DEUTSCHE BK AG LDN BRH 11.79 50,000.000 589,500.00 352,529.00 236,971.00 DBL LONG ETN38 25154H55.8 DAG JP Morgan Account Page 5 of 32 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00016614 SDNY_GM_00285812 EFTA01493716

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.